pharmaceutical manufacturers
Trump Administration Teases MFN Drug Pricing Rule as Commitment Deadline Looms for Companies
Trump administration; Most-Favored-Nation (MFN) pricing; drug pricing; executive order; pharmaceutical manufacturers; Medicaid; direct-to-consumer sales; price parity; commitment deadline; tariffs; international reference price